Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 506 entries
View as:

Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT00003887 Org: User:
Start: 08/31/98 End: 02/28/03 Due: 02/28/04

INSPIRE: Internet and Social-media Program With Information and Resources for Long-Term Cancer Survivors Who Underwent Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT01602211 Org: User:
Start: 05/14/13 End: 11/28/16 Due: 11/28/17

An Escape Room Intervention to Help Improve Breast Cancer Patients' Ability to Navigate Online Access to Nutrition Information

Phase: N/A Priority: Normal
NCT ID: NCT06193070 Org: User:
Start: 03/07/24 End: 06/22/24 Due: 06/22/25

Peer PrEP Referral + HIV Self-test Delivery for PrEP Initiation in Kenya

Phase: N/A Priority: Normal
NCT ID: NCT04982250 Org: User:
Start: 02/24/22 End: 08/27/24 Due: 08/27/25

Self-Management Program and Survivorship Care Plan in Improving the Health of Cancer Survivors After Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT03125070 Org: User:
Start: 10/29/20 End: 12/31/23 Due: 12/31/24

Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00118352 Org: User:
Start: 03/31/05 End: 05/26/15 Due: 05/26/16

Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease

Phase: N/A Priority: Normal
NCT ID: NCT00719888 Org: User:
Start: 11/18/05 End: 12/19/24 Due: 12/19/25

Diet and Physical Activity Intervention for the Prevention of ADT-Induced Metabolic Changes in Patients With Prostate Cancer, TRIPLE-A PILOT Study

Phase: N/A Priority: Normal
NCT ID: NCT04870515 Org: User:
Start: 11/04/21 End: 12/18/24 Due: 12/18/25

Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00112593 Org: User:
Start: 11/30/99 End: - Due: -

Glucosamine and Chondroitin in Gut in Preventing People From Inflammation

Phase: N/A Priority: Normal
NCT ID: NCT03963323 Org: User:
Start: 05/11/18 End: 03/31/19 Due: 03/31/20

Erlotinib, Docetaxel, and Carboplatin in Treating Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00217529 Org: User:
Start: 06/30/04 End: - Due: -

Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05098210 Org: User:
Start: 06/09/22 End: 11/01/26 Due: 11/01/27

Alternating Ixazomib Citrate and Lenalidomide as Maintenance Therapy After Stem Cell Transplant in Treating Patients With Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT02619682 Org: User:
Start: 12/30/15 End: 10/31/25 Due: 10/31/26

Radiolabeled BC8 Antibody, Busulfan, Cyclophosphamide Followed by Donor Stem Cell Transplant in Treating Patients With Acute Myelogenous Leukemia in First Remission

Phase: N/A Priority: Normal
NCT ID: NCT00005940 Org: User:
Start: 10/31/99 End: - Due: -

Resistance Training Program and Cardiovascular Exercise in Increasing Muscle Mass in Adolescent and Young Adult Stem Cell Transplant Survivors

Phase: N/A Priority: Normal
NCT ID: NCT03672981 Org: User:
Start: 11/21/18 End: 10/31/20 Due: 10/31/21

Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT01206309 Org: User:
Start: 03/31/11 End: 10/31/16 Due: 10/31/17

Pilot Trial of a Telephone Weight Loss, Nutrition, Exercise Study

Phase: N/A Priority: Normal
NCT ID: NCT03738540 Org: User:
Start: 08/29/18 End: 12/31/20 Due: 12/31/21

Biological Therapy in Treating Patients With Myelodysplastic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00005853 Org: User:
Start: 12/31/99 End: 08/31/05 Due: 08/31/06

Effects of Sulforaphane on Normal Prostate Tissue

Phase: N/A Priority: Normal
NCT ID: NCT00946309 Org: User:
Start: 07/31/10 End: 05/31/15 Due: 05/31/16

Lenalidomide With or Without Rituximab in Treating Patients With Progressive or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocytic Leukemia, or Non-Hodgkin Lymphoma Previously Treated With Donor Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT01419795 Org: User:
Start: 05/31/12 End: - Due: -

Monoclonal Antibody Therapy, Cyclophosphamide, and Total-Body Irradiation Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Recurrent Acute Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00003870 Org: User:
Start: 02/28/99 End: 11/30/01 Due: 11/30/02

Sonrotoclax, Rituximab, and Zanubrutinib in Treating Participants With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Mantle Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT06839053 Org: User:
Start: 06/02/25 End: 07/01/32 Due: 07/01/33

Phase I Open Label BCG Clinical Trial Assessing TB Drugs and Vaccines

Phase: N/A Priority: Normal
NCT ID: NCT05592223 Org: User:
Start: 12/06/22 End: 12/01/23 Due: 12/01/24

Close Assessment and Testing for Chronic Graft Versus Host Disease, CATCH Study

Phase: N/A Priority: Normal
NCT ID: NCT04188912 Org: User:
Start: 09/13/19 End: 10/15/25 Due: 10/15/26

EQQUAL-NM for the Promotion of Smoking Cessation in Sexual and Gender Minority Young Adults in New Mexico

Phase: N/A Priority: Normal
NCT ID: NCT06386432 Org: User:
Start: 09/01/25 End: 04/01/26 Due: 04/01/27